128 related articles for article (PubMed ID: 29219987)
1. A firm shift.
Nature; 2017 Dec; 552(7683):S6-S7. PubMed ID: 29219987
[No Abstract] [Full Text] [Related]
2. Outsourcing discovery.
Mallapaty S
Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
[No Abstract] [Full Text] [Related]
3. Papers to patents.
Arora A; Belenzon S; Patacconi A
Nature; 2017 Dec; 552(7683):S10. PubMed ID: 29219977
[No Abstract] [Full Text] [Related]
4. Industry links boost research output.
Savage N
Nature; 2017 Dec; 552(7683):S11-S13. PubMed ID: 29220000
[No Abstract] [Full Text] [Related]
5. Decoding the literature on genetic variation.
Coronini R; de Looze MA; Puget P; Bley G; Ramani SV
Nat Biotechnol; 2003 Jan; 21(1):21-9. PubMed ID: 12511903
[No Abstract] [Full Text] [Related]
6. Academic partnerships 2014.
Huggett B
Nat Biotechnol; 2015 Apr; 33(4):333. PubMed ID: 25850049
[No Abstract] [Full Text] [Related]
7. The power of many.
Sansom C
Nat Biotechnol; 2011 Mar; 29(3):201-3. PubMed ID: 21390017
[No Abstract] [Full Text] [Related]
8. The changing face of industry.
Cyranoski D
Nature; 2015 Dec; 528(7582):S184-6. PubMed ID: 26673026
[No Abstract] [Full Text] [Related]
9. Biotechnology: Virtual reality.
Ledford H
Nature; 2013 Jun; 498(7452):127-9. PubMed ID: 23745189
[No Abstract] [Full Text] [Related]
10. Patent drop reveals pressures on industry.
Lawrence S
Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
[No Abstract] [Full Text] [Related]
11. Biotech patenting slows in 2004.
Lawrence S
Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
[No Abstract] [Full Text] [Related]
12. The promise of the East: India and China as R&D options.
Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
[No Abstract] [Full Text] [Related]
13. Academic-industry partnerships 2012.
Huggett B
Nat Biotechnol; 2013 May; 31(5):383. PubMed ID: 23657385
[No Abstract] [Full Text] [Related]
14. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
[TBL] [Abstract][Full Text] [Related]
15. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
16. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
17. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
18. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
[TBL] [Abstract][Full Text] [Related]
19. Brokering knowledge in biosciences with InnoCentive. Interview by Semahat S. Demir.
Hussein A
IEEE Eng Med Biol Mag; 2003; 22(4):26-7. PubMed ID: 14515687
[No Abstract] [Full Text] [Related]
20. The extended pharmaceutical enterprise.
Cavalla D
Drug Discov Today; 2003 Mar; 8(6):267-74. PubMed ID: 12623241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
